Skip to content
Search

Latest Stories

Lenmeldy, a lifesaving gene therapy, now the world's most expensive drug

Striking about 1 in 100,000 newborns, MLD is a rare, rapidly worsening, and fatal nervous system disorder.

Lenmeldy, a lifesaving gene therapy, now the world's most expensive drug

Lenmeldy, a new gene therapy for the rare and fatal childhood disease metachromatic leukodystrophy (MLD), has become the world's most expensive drug, at a whopping $4.25 million (£3.350 million).

MLD is a brutal illness that strikes toddlers and affects their ability to walk and talk. It's a heartbreaking reality for families, with roughly half of the afflicted children succumbing to the disease, while the others live on in a vegetative state.


However, MLD is also incredibly rare, affecting only around 40 children annually in the United States. This very rarity lies at the heart of the soaring price tags associated with new gene therapies like Lenmeldy. Consider the economics: Orchard employs a staff of 160, a stark contrast to the limited number of children they can treat over several years.

“My heart wants to talk about what an effect this therapy has had on these children. Without it, they will die very young or live for many years in a vegetative state. But kids who get the gene therapy, mostly end up being able to walk and do well cognitively. The ones we treat are going to school, they’re playing sports, and they are able to tell their stories,” says Orchard’s chief medical officer, Leslie Meltzer.

While the manufacturer, Orchard Therapeutics, justifies this astronomical cost by highlighting the treatment's potential to cure a deadly disease, affordability and accessibility remain major concerns.

This raises questions about the commercial viability of Lenmeldy, even at its current price. Experts predict a challenging journey, citing the past struggles of gene therapies on the market. The European experience with Lenmeldy, approved there three years ago at a slightly lower price, reflects this. Orchard generated a mere $12.7 million (£10.04 million) from sales for most of last year, a clear indication of the limited number of children treated.

Despite the financial concerns, Lenmeldy offers a glimmer of hope. The treatment works by adding a missing gene to a child's bone marrow cells, effectively reversing the root cause of the disease in the brain. Children who participated in trials that began in 2010 are now living normal lives, a testament to the therapy's effectiveness.

Independent groups also support the value of Lenmeldy. The Institute for Clinical and Economic Review, which assesses drug value, estimates the treatment to be cost-effective within a range of £1.8 million to £3.08 million. However, super-high prices can signal economic unsustainability. A previous record holder, the gene therapy Glybera for a different condition, was purchased only once before being pulled from the market due to its $1 million price tag, which couldn't be justified by its limited effectiveness.

gene therapy Five specialised treatment centres being qualified across the US to minimise travel burden on eligible patients and their families (Representative image: iStock)

Hemgenix, a £2.7 million gene therapy for haemophilia, held the title of the most expensive drug until Lenmeldy's arrival. Although these therapies were envisioned to generate billions in sales, news reports suggest a lower-than-expected uptake.

Orchard itself discontinued another gene therapy, Strimvelis, which offered a cure for a specific immune deficiency. The limited patient pool and the existence of an alternative treatment proved to be insurmountable hurdles, even with a money-back guarantee. Orchard was subsequently acquired by the Japanese drug company Kyowa Kirin.

The success of Lenmeldy hinges on early testing. Once symptoms develop, it might be too late. Currently, many cases are identified only because an older sibling succumbed to the inherited condition.

Early detection through newborn screening programs could be a game-changer, allowing for timely intervention and potentially saving countless lives. A decision on newborn screening for MLD is expected in May 2024.

Amy Price, a parent who lost one child to MLD but saved two others with Lenmeldy, exemplifies the human impact of this treatment. Her two treated children are now thriving teenagers.

While acknowledging the high cost, this treatment emphasises the long-term benefits compared to the financial burden of caring for an untreated child.

Lenmeldy represents a significant breakthrough in gene therapy. However, its high cost and the rarity of the disease it treats create significant challenges. Increased access through early testing and insurance coverage will be crucial for maximising the life-saving potential of this groundbreaking treatment.

Teddi Shaw, a toddler with a rare genetic disease, became the first child in the UK in 2023 to receive life-saving gene therapy on the NHS. last year, in February. The treatment, Libmeldy, is very expensive but could not help Teddi's older sister Nala, who was diagnosed too late.

Both girls have MLD, a fatal condition that attacks the brain and nervous system. Nala started showing symptoms first, like uncoordinated walking and tremors. The doctors initially dismissed the parents' concerns but later confirmed it was MLD.

Sadly, by the time Nala was diagnosed, the new gene therapy was no longer an option for her. Now terminally ill, Nala can only receive supportive care.

More For You

Donald Trump

The latest tariffs are part of Trump’s broader effort to address what he claims are unfair trade practices

Getty

Trump pressures UK to accept chlorinated chicken for tariff relief

Britain is facing renewed pressure from the United States to lift its ban on chlorinated chicken as a condition for tariff relief, following the imposition of sweeping new trade barriers by Donald Trump’s administration. The US president has introduced a 10 per cent tariff on all British exports to the United States, with even steeper levies placed on imports from the European Union.

US tariffs and trade demands

The latest tariffs are part of Trump’s broader effort to address what he claims are unfair trade practices. The White House, in its announcement, criticised the UK’s “non-science-based standards” that restrict American agricultural imports, including poultry and beef. It argued that these trade policies act as non-tariff barriers that disadvantage US exporters.

Keep ReadingShow less
8 packaged foods recalled in UK in the last month

These food recalls show how important it is to check labels and stay updated on safety alerts

iStock

8 packaged foods recalled in UK in the last month

Food recalls in the UK are issued when products pose risks to consumers. These risks can range from contamination to allergen mislabelling, and staying informed about these recalls is crucial for consumer safety. Recent recalls emphasize the importance of vigilance when purchasing and consuming food items. If you’ve recently stocked up on groceries, it’s time to check your pantry and fridge to ensure none of the items listed below are affected.

1. Tony’s Chocolonely Chocolate Bars

On April 2, 2025, Tony’s Chocolonely recalled its Dark Almond Sea Salt & Everything Bar after discovering small stones in the product. The presence of foreign objects in food can pose serious risks, such as dental damage or choking hazards. The company has urged customers to return the affected items immediately to avoid potential harm. If you have recently purchased this product, check your packaging and return it to the store where it was bought for a full refund.

Keep ReadingShow less
Priyanka Chopra’s Skincare Secret for a Radiant Glow

A glimpse into the secret behind her flawless, dewy glow

Instagram/ priyankachopra

Priyanka Chopra shares her skincare secret for achieving the ultimate glow

Global icon Priyanka Chopra Jonas has once again mesmerized fans, not just with her undeniable star power but also with her radiant beauty and touching personal moments. The actress recently took to social media to unveil her simple yet effective skincare ritual, offering a glimpse into the secret behind her flawless, dewy glow.

A glow that speaks volumes

Priyanka’s skincare revelation came via her Instagram stories, where she showcased the results of her go-to beauty practice, a sheet mask. The actress shared snapshots flaunting her luminous complexion post-skincare, proving that sometimes, the simplest routines yield the most stunning results.

Keep ReadingShow less
Meghan Markle

Meghan remains optimistic about the future of her brand

Getty

Meghan Markle’s ‘As Ever’ products sell out in just 30 minutes, including £21.60 honey jars

Meghan Markle’s latest business venture, the As Ever lifestyle range, has made a remarkable debut, with products selling out in under 30 minutes. The highly anticipated collection, which features a selection of premium artisanal goods, has garnered immediate consumer interest and social media excitement.

Among the standout products was a jar of wildflower honey with honeycomb, priced at $28 (£21.60), which quickly disappeared from the online store. Other sought-after items included flower sprinkles at $15 (£11.60), raspberry jam at $14 (£10.80), and a selection of herbal teas and baking mixes, each ranging between $12 (£9.30) and $14 (£10.80). The rapid sell-out reflects Meghan’s growing influence in the lifestyle and wellness market.

Keep ReadingShow less
Kareena Kapoor

Striking appearance at the Vivienne Westwood show

Instagram/ kareenakapoorkhan

Kareena Kapoor dazzles in red at Vivienne Westwood show in Mumbai

Bollywood star Kareena Kapoor made a striking appearance at the Vivienne Westwood show in Mumbai on Tuesday evening, turning heads in a glamorous red ensemble. The event, held at the iconic Gateway of India, was a celebration of India’s rich textile heritage and featured an exclusive showcase of Vivienne Westwood’s Spring-Summer 2025 collection.

A show-stopping look

Kareena Kapoor, known for her impeccable fashion sense, was the cynosure of all eyes as she arrived in a stunning red gown featuring a thigh-high slit, corset bodice, and off-shoulder sleeves. Her outfit exuded elegance and sophistication, complemented by her gold-hued heels, which added a touch of glamour to her look.

Keep ReadingShow less